663171-32-2Relevant academic research and scientific papers
CD16A BINDING AGENTS AND USES THEREOF
-
Paragraph 00340; 00343-00344; 00359; 00362-00363; 00378, (2019/07/20)
Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.
